Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.

Collaboration aimed at accelerating R&D in both small- and large-molecule analysis and building high-impact capabilities in fast-growing Asian markets KUALA LUMPUR, Malaysia, /PRNewswire/ -- Agilent ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful ...

Cincinnati's 1819 Venture Lab Demo Day showcases local health care innovations, highlighting the city's growing role in the ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

Just 10 years ago, there was virtually no biopharmaceutical industry in China. But now, almost all global big pharma ...

Join Bisnow’s Chicago Quantum & Life Science Forum - the only event bringing together researchers, entrepreneurs, investors ...

The FDA has named Tracy Beth Høeg, M.D., Ph.D., as acting director of its Center for Drug Evaluation and Research, continuing ...

Angelini’s investments will be made through its Angelini Ventures arm. EIB and Angelini plan to support between seven and 10 ...